Hepcinat-LP (ledipasvir 90mg/sofosbuvir 400mg)

New product

$217.00

$217.00 per 28 Tablets

Indications & Dosage

Hepcinat-LP, also known as  Hepcvilr L, Myhep lvir” is a fixed-dose combination of Sofosbuvir and Ledipasvir indicated for the treatment of chronic hepatitis C virus (HCV). Hepcinat-LP combines Sofosbuvir 400mg and Ledipasvir90mg. Its Cure rates is 94% to 99% for hepatitis C. 

Hepcinat-LP is a generic prescription medicine from Natco, which is one of the biggest pharmaceutical company in India.

Hepcinat-LP Dosage:

For the treatment of chronic hepatitis C infection.
For the treatment of chronic hepatitis C virus (HCV) genotype 1 infection.
Oral dosage
Treatment-naive Adults without cirrhosis

1 tablet (90 mg ledipasvir; 400 mg sofosbuvir) PO once daily with or without food. The recommended duration of treatment is 12 weeks; however, an 8-week treatment duration can be considered for those patients with a baseline hepatitis C virus RNA less than 6 million international units/mL. Recommendation includes patients coinfected with HIV.

Treatment-naive Adults with compensated (Child-Pugh A) cirrhosis

1 tablet (90 mg ledipasvir; 400 mg sofosbuvir) PO once daily with or without food. The recommended duration of treatment is 12 weeks. Recommendation includes patients coinfected with HIV.

Treatment-experienced Adults without cirrhosis

1 tablet (90 mg ledipasvir; 400 mg sofosbuvir) PO once daily with or without food. The recommended duration of treatment is 12 weeks. Recommendation includes patients coinfected with HIV.

Treatment-experienced Adults with compensated (Child-Pugh A) cirrhosis

1 tablet (90 mg ledipasvir; 400 mg sofosbuvir) PO once daily with or without food. The recommended duration of treatment is 24 weeks. Alternatively, treatment duration may be reduced to 12 weeks if ledipasvir; sofosbuvir is administered in combination with ribavirin. Ribavirin must be administered with food in 2 divided doses, and the dose is based on weight as follows: less than 75 kg give 500 mg PO twice daily; 75 kg or more give 600 mg PO twice daily. Recommendation includes patients coinfected with HIV.

Treatment-naive and experienced Adults with decompensated (Child-Pugh B or C) cirrhosis

1 tablet (90 mg ledipasvir; 400 mg sofosbuvir) PO once daily with ribavirin (600 mg PO once daily) for 12 weeks. Ribavirin must be administered with food, and if tolerated, the dose may be increased as follows: if less than 75 kg give 500 mg PO twice daily; if 75 kg or more give 600 mg PO twice daily. Consider decreasing ribavirin dose for abnormal hemoglobin. Recommendation includes patients coinfected with HIV. For patients unable to take ribavirin, guidelines recommend 1 tablet PO once daily for 24 weeks.

Treatment-naive and experienced Adults who have undergone liver transplantation and are without cirrhosis or have compensated (Child-Pugh A) cirrhosis

1 tablet (90 mg ledipasvir; 400 mg sofosbuvir) PO once daily with ribavirin for 12 weeks. Ribavirin must be administered with food in 2 divided doses, and the dose is based on weight as follows: less than 75 kg give 500 mg PO twice daily; 75 kg or more give 600 mg PO twice daily. Recommendation includes patients coinfected with HIV.

Treatment-naive and experienced Adults who have undergone liver transplantation and have decompensated (Child-Pugh B or C) cirrhosis†

Guidelines recommend 1 tablet (90 mg ledipasvir; 400 mg sofosbuvir) PO once daily with low initial dose of ribavirin for 12 weeks as the preferred regimen. Increase ribavirin dose as tolerated.

Treatment-naive Children and Adolescents 12 to 17 years without cirrhosis or with compensated (Child-Pugh A) cirrhosis

1 tablet (90 mg ledipasvir; 400 mg sofosbuvir) PO once daily with or without food. The recommended duration of treatment is 12 weeks. Recommendation includes patients coinfected with HIV. 

Treatment-experienced Children and Adolescents 12 to 17 years without cirrhosis

1 tablet (90 mg ledipasvir; 400 mg sofosbuvir) PO once daily with or without food. The recommended duration of treatment is 12 weeks. Recommendation includes patients coinfected with HIV. 

Treatment-experienced Children and Adolescents 12 to 17 years with compensated (Child-Pugh A) cirrhosis

1 tablet (90 mg ledipasvir; 400 mg sofosbuvir) PO once daily with or without food. The recommended duration of treatment is 24 weeks. Recommendation includes patients coinfected with HIV. 

Treatment-naive Children younger than 12 years weighing at least 35 kg without cirrhosis or with compensated (Child-Pugh A) cirrhosis

1 tablet (90 mg ledipasvir; 400 mg sofosbuvir) PO once daily with or without food. The recommended duration of treatment is 12 weeks. Recommendation includes patients coinfected with HIV. 

Treatment-experienced Children younger than 12 years weighing at least 35 kg without cirrhosis

1 tablet (90 mg ledipasvir; 400 mg sofosbuvir) PO once daily with or without food. The recommended duration of treatment is 12 weeks. Recommendation includes patients coinfected with HIV. 

Treatment-experienced Children younger than 12 years weighing at least 35 kg with compensated (Child-Pugh A) cirrhosis

1 tablet (90 mg ledipasvir; 400 mg sofosbuvir) PO once daily with or without food. The recommended duration of treatment is 24 weeks. Recommendation includes patients coinfected with HIV. 

For the treatment of chronic hepatitis C virus (HCV) genotypes 5 or 6 infection.
Oral dosage
Treatment-naive and experienced Adults without cirrhosis or who have compensated (Child-Pugh A) cirrhosis

1 tablet (90 mg ledipasvir; 400 mg sofosbuvir) PO once daily with or without food. The recommended duration of treatment is 12 weeks. Recommendation includes patients coinfected with HIV.

Treatment-naive and experienced Adults with decompensated (Child-Pugh B or C) cirrhosis†

Guidelines recommend 1 tablet (90 mg ledipasvir; 400 mg sofosbuvir) PO once daily with low initial dose of ribavirin for 12 weeks as a preferred regimen. Increase ribavirin dose as tolerated. For patients unable to take ribavirin, guidelines recommend 1 tablet PO once daily for 24 weeks.

Treatment-naive and experienced Adults who have undergone liver transplantation and are without cirrhosis or have compensated (Child-Pugh A) cirrhosis†

Guidelines recommend 1 tablet (90 mg ledipasvir; 400 mg sofosbuvir) PO once daily with weight-based ribavirin for 12 weeks as a preferred regimen.

Treatment-naive and experienced Adults who have undergone liver transplantation and have decompensated (Child-Pugh B or C) cirrhosis†

Guidelines recommend 1 tablet (90 mg ledipasvir; 400 mg sofosbuvir) PO once daily with low initial dose of ribavirin for 12 weeks as the preferred regimen. Increase ribavirin dose as tolerated.

Treatment-naive and experienced Children and Adolescents 12 to 17 years without cirrhosis or who have compensated (Child-Pugh A) cirrhosis

1 tablet (90 mg ledipasvir; 400 mg sofosbuvir) PO once daily with or without food. The recommended duration of treatment is 12 weeks. Recommendation includes patients coinfected with HIV. 

Treatment-naive and experienced Children younger than 12 years weighing at least 35 kg without cirrhosis or who have compensated (Child-Pugh A) cirrhosis

1 tablet (90 mg ledipasvir; 400 mg sofosbuvir) PO once daily with or without food. The recommended duration of treatment is 12 weeks. Recommendation includes patients coinfected with HIV. 

For the treatment of chronic hepatitis C virus (HCV) genotype 4 infection.
Oral dosage
Treatment-naive and experienced Adults without cirrhosis or who have compensated (Child-Pugh A) cirrhosis

1 tablet (90 mg ledipasvir; 400 mg sofosbuvir) PO once daily with or without food. The recommended duration of treatment is 12 weeks. Recommendation includes patients coinfected with HIV.

Treatment-naive and experienced Adults with decompensated (Child-Pugh B or C) cirrhosis†

Guidelines recommend 1 tablet (90 mg ledipasvir; 400 mg sofosbuvir) PO once daily with low initial dose of ribavirin for 12 weeks as a preferred regimen. Increase ribavirin dose as tolerated. For patients unable to take ribavirin, guidelines recommend 1 tablet PO once daily for 24 weeks.

Treatment-naive and experienced Adults who have undergone liver transplantation and are without cirrhosis or have compensated (Child-Pugh A) cirrhosis

1 tablet (90 mg ledipasvir; 400 mg sofosbuvir) PO once daily with ribavirin for 12 weeks. Ribavirin must be administered with food in 2 divided doses, and the dose is based on weight as follows: less than 75 kg give 500 mg PO twice daily; 75 kg or more give 600 mg PO twice daily. Recommendation includes patients coinfected with HIV.

Treatment-naive and experienced Adults who have undergone liver transplantation and have decompensated (Child-Pugh B or C) cirrhosis†

Guidelines recommend 1 tablet (90 mg ledipasvir; 400 mg sofosbuvir) PO once daily with low initial dose of ribavirin for 12 weeks as the preferred regimen. Increase ribavirin dose as tolerated.

Treatment-naive and experienced Children and Adolescents 12 to 17 years without cirrhosis or who have compensated (Child-Pugh A) cirrhosis

1 tablet (90 mg ledipasvir; 400 mg sofosbuvir) PO once daily with or without food. The recommended duration of treatment is 12 weeks. Recommendation includes patients coinfected with HIV. 

Treatment-naive and experienced Children younger than 12 years weighing at least 35 kg without cirrhosis or who have compensated (Child-Pugh A) cirrhosis

1 tablet (90 mg ledipasvir; 400 mg sofosbuvir) PO once daily with or without food. The recommended duration of treatment is 12 weeks. Recommendation includes patients coinfected with HIV. 

Hepcinat-LP Side Effects:

Hepatitis B virus reactivation: Before starting treatment with Hepcinat-LP, your healthcare provider will do blood tests to check for hepatitis B virus infection. If you have ever had hepatitis B virus infection, the hepatitis B virus could become active again during or after treatment of hepatitis C virus with Hepcinat-LP. Hepatitis B virus becoming active again (called reactivation) may cause serious liver problems including liver failure and death. Your healthcare provider will monitor you if you are at risk for hepatitis B virus reactivation during treatment and after you stop taking 

Hepcinat-LP PI

For more Prescribing information,please ask for “ Prescribing Information” from our customer supporter.

Additional Info

Package Quantity28
WarningsDon't take the drug without consulting a qualified doctor or physician.
Suggested useFollow the doctor's advice
By symptomHepcinat-LP is used to treat chronic hepatitis C in adults with HCV genotype 1, 4, 5, or 6.
Delivery & Returns7-14 Days

Reviews

Grade 
2020-11-28 22:21:38
Hepcinat lp

I wanted to say thank you, your company has been extremely professional, and timely in handling my orders. I could not ask for better service Than BON HOA HEALTH... Hope all of you are well, and have a great holiday season... 2021 will be a great year!!!

Thanks again

    Grade 
    2020-09-08 03:30:01
    The generic medicine works good

    Thank you all for your time. I appreciate the effort from all of you. You folks be safe, the covid 19 virus is very bad here.

      Grade 
      2018-07-20 11:22:25
      Worth every penny

      Great product, already after 4 weeks there is no trace of disease, looks like no side effects either. Thanks a lot!!!

        Grade 
        2018-07-16 09:33:43
        Thanks and recommend

        I have finally picked up the parcel!!!it is important that it has finally arrived and that I can start with the therapy and hope it will work for me. Thank you very much for your efforts and your concern, I can only recommend your company to anybody who needs your products or services.

          Grade 
          2018-04-20 02:01:18
          Glad that I chose this company

          I received the package today and all looks good. I want to thank you for your outstanding service. I'm really glad that I chose this company. Once again thank you!

            Grade 
            2018-01-16 04:08:15
            Helps me a lot!!!

            Well...Put simply it was awesome. I took my first blood work at 14 days and a high 18 year viral load was gone. I don't feel and extra discomfort from normal. Just wished it was out back in the 90's. I then took all the rest of the days thinking it was unnecessary Test after a month maximu. Bonhoa Pharmacy really gives a lot of help.

              Grade 
              2017-12-08 08:50:31
              Thanks

              I started taking Indian Hepcinat LP for an 8 week period. Yesterday, I had my second viral load blood test and the Hep C I had is completely undetectable. This is considered a complete cure in the medical world. Wow, I feel very good now.

                Grade 
                2017-12-04 03:16:28
                I am cured

                I fought my insurance company for 2 years and finally bought the generic pharmacy overseas myself form the online pharmacy. Thank you Hepcinat-LP, I am cured!!!!!!

                  Grade 
                  2017-11-22 22:43:25
                  Good to share with you

                  I took the medication for 12 weeks with almost no side affects. I had more energy at 1 month into the treatment. The only side effects were some rashes after I finished the treatment. I got my results yesterday and no hep c 3 months after treatment!!! I'm relieved and also thankful I can live to see my children grow up.

                    Write your review!

                    Write a review

                    Hepcinat-LP (ledipasvir 90mg/sofosbuvir 400mg)

                    Hepcinat-LP (ledipasvir 90mg/sofosbuvir 400mg)

                    Ledipasvir 90mg/Sofosbuvir 400mg

                    Accessories

                    30 other products in the same category: